Cancer of Ovary

14 registered clinical trials studyying Cancer of Ovary — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy NCT06268665	University of California, Davis	Phase 2
Terminated	Promitil Treatment of Patients With Solid Tumors Associated With Deleterious Mutations Who Have Progressed Aft NCT06478862	Lipomedix Pharmaceuticals Inc.	Phase 2
Terminated	NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid NCT05252390	Nuvation Bio Inc.	Phase 1
Unknown	Efficacy and Safety of Involving Field Radiotherapy in the Oligo-lesions(Metastasis/Recurrent/Refractory) of O NCT05059782	Xi'an Jiaotong University	N/A
Unknown	Immunoassay and Regulation of Traditional Chinese Medicine on Cancer Patients NCT04438564	China Medical University Hospital	N/A
Completed	The Effect of Logotherapy on Mental Health in Gynecological Cancer Patients NCT05246462	Akdeniz University	N/A
Terminated	The Safety and Antitumor Activity of the Combination of Oregovomab and Hiltonol in Recurrent Advanced Ovarian NCT03162562	CanariaBio Inc.	Phase 1
Completed	Radiotherapy Assessments During Intervention ANd Treatment (RADIANT) NCT03133286	DxTerity Diagnostics	—
Terminated	MEDI4736 (Durvalumab) in Patients With Brain Metastasis From Epithelial-derived Tumors NCT02669914	Washington University School of Medicine	Phase 2
Withdrawn	Identification and Characterization of Ovarian Cancer and Endometrial Cancer Specific Biomarkers in Vaginal Fl NCT02704650	Shaare Zedek Medical Center	N/A
Completed	MRI-Guided Stereotactic Body Radiation Therapy (SBRT) for Ovarian Cancer NCT02582931	Washington University School of Medicine	Phase 1
Terminated	Intensive Locoregional Chemoimmunotherapy for Recurrent Ovarian Cancer Plus Intranodal DC Vaccines NCT02432378	Roswell Park Cancer Institute	Phase 1 / Phase 2
Terminated	Fenretinide/LXS Oral Powder Plus Ketoconazole in Recurrent Ovarian Cancer NCT01535157	South Plains Oncology Consortium	Phase 1 / Phase 2
Completed	Validation of a Laparoscopic Score to Predict the Chance of Optimal Cytoreduction in Advanced Ovarian Cancer P NCT01595204	Catholic University of the Sacred Heart	N/A